OptimizeRx Launches Micro-Neighborhood Targeting, Offered On The Co's Dynamic Audience Activation Platform, Further Unifing Outreach To Patient And Provider Audiences Via The Incorporation Of Brand Eligibility Signals To Consumer Marketing
OptimizeRx Launches Micro-Neighborhood Targeting, Offered On The Co's Dynamic Audience Activation Platform, Further Unifing Outreach To Patient And Provider Audiences Via The Incorporation Of Brand Eligibility Signals To Consumer Marketing
The availability of Micro-Neighborhood Targeting on the Company's Dynamic Audience Activation Platform meets the demand of life sciences marketers by synchronizing consumer and physician marketing
該公司的動態受衆激活平台上提供的微鄰域定向功能可通過同步消費者和醫生的營銷來滿足生命科學營銷人員的需求
OptimizeRx presents panel session at Digital Pharma East: Unlocking Opportunity through HCP+DTC Alignment in Omnichannel Oncology Marketing
OptimizerX 在 Digital Pharma East 上舉行小組會議：通過全渠道腫瘤學營銷中的HCP+DTC協調釋放機遇
WALTHAM, Ma., Sept. 09, 2024 (GLOBE NEWSWIRE) -- OptimizeRx Corp. (the "Company") (NASDAQ:OPRX), a leading provider of healthcare technology solutions helping life sciences companies reach and engage healthcare professionals (HCPs) and prospective patients, today announces the leading AI-driven marketing technology for healthcare consumers, Micro-Neighborhood Targeting (MNT), offered on the Company's Dynamic Audience Activation Platform (DAAP), which now further unifies outreach to patient and provider audiences via the incorporation of brand eligibility signals to consumer marketing. This enhancement to DAAP enables pharmaceutical brands to deliver synchronized, AI-guided Direct-to-Consumer (DTC) and HCP campaigns, with the mission to improve the dialogue between patients and physicians throughout the treatment journey.
馬薩諸塞州沃爾瑟姆，2024年9月9日（GLOBE NEWSWIRE）——幫助生命科學公司接觸和吸引醫療保健專業人員（HCP）和潛在患者的醫療保健技術解決方案的領先提供商OptimizerX公司（「公司」）（納斯達克股票代碼：OPRX）今天宣佈在公司的動態受衆激活平台（DAAP）上爲醫療保健消費者提供領先的人工智能驅動營銷技術——微鄰域定位（MNT），它現在通過整合品牌資格信號，進一步統一了對患者和醫療服務提供者受衆的宣傳到消費者營銷。對DAAP的這一增強使製藥品牌能夠同步開展由人工智能指導的直接面向消費者（DTC）和HCP活動，其使命是改善整個治療過程中患者與醫生之間的對話。
